Cargando…

Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma

BACKGROUND: Drug resistance to sorafenib greatly limited the benefits of treatment in patients with hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) participate in the development of drug resistance. The key miRNA regulators related to the clinical outcome of sorafenib treatment and their molecula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yuanjun, Chan, Yau-Tuen, Tan, Hor-Yue, Zhang, Cheng, Guo, Wei, Xu, Yu, Sharma, Rakesh, Chen, Zhe-Sheng, Zheng, Yi-Chao, Wang, Ning, Feng, Yibin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722264/ https://www.ncbi.nlm.nih.gov/pubmed/34980204 http://dx.doi.org/10.1186/s13046-021-02208-x

Ejemplares similares

Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
por: Lu, Yuanjun, et al.
Publicado: (2020)

ACSL3 and ACSL4, Distinct Roles in Ferroptosis and Cancers
por: Yang, Yufei, et al.
Publicado: (2022)

ABHD12 contributes to tumorigenesis and sorafenib resistance by preventing ferroptosis in hepatocellular carcinoma
por: Cai, Mengxing, et al.
Publicado: (2023)

The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
por: Yuan, Hongchao, et al.
Publicado: (2021)

PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma
por: Wang, Ning, et al.
Publicado: (2021)

Thioredoxin-interacting protein-activated intracellular potassium deprivation mediates the anti-tumour effect of a novel histone acetylation inhibitor HL23, a fangchinoline derivative, in human hepatocellular carcinoma
por: Lu, Yuanjun, et al.
Publicado: (2022)

Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma
por: Wu, Junyu, et al.
Publicado: (2023)

lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p/ACSL4 Axis in Diabetic Retinopathy
por: Liu, Yu, et al.
Publicado: (2022)

ACSL4 suppresses glioma cells proliferation via activating ferroptosis
por: Cheng, Jing, et al.
Publicado: (2020)

Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
por: Xia, Huawei, et al.
Publicado: (2021)

ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity
por: Gan, Boyi
Publicado: (2022)

ACSL4 contributes to ferroptosis‐mediated rhabdomyolysis in exertional heat stroke
por: He, Sixiao, et al.
Publicado: (2022)

ACSL4 is essential for radiation-induced intestinal injury by initiating ferroptosis
por: Ji, Qian, et al.
Publicado: (2022)

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
por: Grube, Julia, et al.
Publicado: (2022)

CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives
por: Chan, Yau-Tuen, et al.
Publicado: (2022)

Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis
por: Chan, Yau-tuen, et al.
Publicado: (2023)

LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy
por: Fang, Xiangdong, et al.
Publicado: (2023)

Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion
por: Tuo, Qing-zhang, et al.
Publicado: (2022)

Relationship Between ACSL4-Mediated Ferroptosis and Chronic Obstructive Pulmonary Disease
por: Wang, Yingxi, et al.
Publicado: (2023)

Vitamin D Attenuates Ulcerative Colitis by Inhibiting ACSL4-Mediated Ferroptosis
por: Gao, Shuo, et al.
Publicado: (2023)

MiR-23b Promotes Porcine Preadipocyte Differentiation via SESN3 and ACSL4
por: Li, Meng, et al.
Publicado: (2022)

Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellular carcinoma cells amplifies the synergistic therapeutic effect of aspirin and sorafenib
por: Xia, Hongping, et al.
Publicado: (2017)

RNA helicase DDX5 modulates sorafenib sensitivity in hepatocellular carcinoma via the Wnt/β-catenin–ferroptosis axis
por: Li, Zhili, et al.
Publicado: (2023)

Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases
por: Ndiaye, Haarith, et al.
Publicado: (2020)

RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis
por: Wang, Mu-En, et al.
Publicado: (2023)

ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury
por: Wang, Yue, et al.
Publicado: (2022)

Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?
por: Chan, Yau-Tuen, et al.
Publicado: (2020)

GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
por: Wang, Qiujie, et al.
Publicado: (2021)

AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis
por: Wang, Qi, et al.
Publicado: (2023)

LncAABR07025387.1 Enhances Myocardial Ischemia/Reperfusion Injury Via miR-205/ACSL4-Mediated Ferroptosis
por: Sun, Weixin, et al.
Publicado: (2022)

Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6/ACSL4 Signaling
por: Tian, Xiangyang, et al.
Publicado: (2021)

Baicalin Prevents Myocardial Ischemia/Reperfusion Injury Through Inhibiting ACSL4 Mediated Ferroptosis
por: Fan, Zhenyu, et al.
Publicado: (2021)

Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma
por: Guo, Na
Publicado: (2022)

PKCβII–ACSL4 pathway mediating ferroptosis execution and anti‐tumor immunity
por: Lei, Guang, et al.
Publicado: (2022)

Integrative analysis links ferroptosis to necrotizing enterocolitis and reveals the role of ACSL4 in immune disorders
por: Dang, Dan, et al.
Publicado: (2022)

ACSL4-Mediated Ferroptosis and Its Potential Role in Central Nervous System Diseases and Injuries
por: Jia, Bowen, et al.
Publicado: (2023)

Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis
por: Merkel, Melanie, et al.
Publicado: (2023)

YAP/ACSL4 Pathway-Mediated Ferroptosis Promotes Renal Fibrosis in the Presence of Kidney Stones
por: Li, Lei, et al.
Publicado: (2023)

Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism
por: Ding, Kaiyue, et al.
Publicado: (2023)

Systematic Review with Meta-Analysis: Effectiveness and Safety of Acupuncture as Adjuvant Therapy for Side Effects Management in Drug Therapy-Receiving Breast Cancer Patients
por: Chan, Yau-Tuen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p1s8hb3822566jp0or07jg4co5